Cantourage Group SE (HIGH.DE) stock: key figures, P/E, revenue and dividend

Health Care · Germany

Price
5.40 EUR
Market cap
67.32 m EUR
P/E (2023)
–
P/S (2023)
2.86
Dividend yield
0.00 %
Net margin
-18.14 %
Return on equity (ROE)
-10.69 %
Return on assets (ROA)
-9.67 %

Cantourage Group SE financials

Fiscal year20222023
Revenue603,307.21 EUR23.56 m EUR
Gross profit–7.41 m EUR
Operating income28,728.92 EUR-4.33 m EUR
EBIT28,728.92 EUR-4.32 m EUR
Net income9,011.43 EUR-4.27 m EUR
Diluted EPS – continuing operations0.00 EUR-0.34 EUR

Full history since 2020, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

About Cantourage Group SE

Cantourage Group SE operates as a medical cannabis company in Europe and internationally. The company offers cannabis flowers, extracts, dronabinol, tetrahydrocannabinol, and cannabidiol products. It exports its products. The company distributes its products through pharmacies, wholesalers, and partners. Cantourage Group SE was founded in 2019 and is headquartered in Berlin, Germany.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 29.10.2026. Details in the risk notice.